

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.24851616 |
| 2 | central nervous system myelination (GO:0022010) | 5.24851616 |
| 3 | macrophage activation involved in immune response (GO:0002281) | 4.71592006 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 4.69053533 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.43164194 |
| 6 | regulation of mononuclear cell migration (GO:0071675) | 4.38734050 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.38497744 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.38497744 |
| 9 | oligosaccharide catabolic process (GO:0009313) | 4.15561317 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 4.02936614 |
| 11 | regulation of activation of Janus kinase activity (GO:0010533) | 3.87614887 |
| 12 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.86373701 |
| 13 | fatty acid elongation (GO:0030497) | 3.81343185 |
| 14 | regulation of chronic inflammatory response (GO:0002676) | 3.79163738 |
| 15 | myeloid dendritic cell differentiation (GO:0043011) | 3.78746932 |
| 16 | positive regulation of heat generation (GO:0031652) | 3.67905192 |
| 17 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.64626842 |
| 18 | regulation of antigen processing and presentation (GO:0002577) | 3.64069415 |
| 19 | glycosphingolipid catabolic process (GO:0046479) | 3.59213153 |
| 20 | myeloid dendritic cell activation (GO:0001773) | 3.55374833 |
| 21 | regulation of T cell tolerance induction (GO:0002664) | 3.53350526 |
| 22 | positive regulation of mast cell activation (GO:0033005) | 3.51991431 |
| 23 | response to protozoan (GO:0001562) | 3.49303944 |
| 24 | positive regulation of mast cell degranulation (GO:0043306) | 3.45528655 |
| 25 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.45528655 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.43938391 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 3.42710067 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.39344594 |
| 29 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.38651001 |
| 30 | regulation of fever generation (GO:0031620) | 3.37677568 |
| 31 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.32410319 |
| 32 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.31458361 |
| 33 | NIK/NF-kappaB signaling (GO:0038061) | 3.31347405 |
| 34 | amino sugar catabolic process (GO:0046348) | 3.29507405 |
| 35 | positive regulation of interleukin-17 production (GO:0032740) | 3.24273873 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24252807 |
| 37 | glycolipid catabolic process (GO:0019377) | 3.22314680 |
| 38 | regulation of memory T cell differentiation (GO:0043380) | 3.19941023 |
| 39 | negative regulation of protein oligomerization (GO:0032460) | 3.19632503 |
| 40 | regulation of podosome assembly (GO:0071801) | 3.14871799 |
| 41 | macrophage activation (GO:0042116) | 3.14849550 |
| 42 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.13647883 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.10651939 |
| 44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.08492277 |
| 45 | positive regulation of isotype switching (GO:0045830) | 3.05860181 |
| 46 | regulation of interleukin-12 production (GO:0032655) | 3.01956440 |
| 47 | type I interferon signaling pathway (GO:0060337) | 3.01291048 |
| 48 | cellular response to type I interferon (GO:0071357) | 3.01291048 |
| 49 | dendritic cell differentiation (GO:0097028) | 3.01015367 |
| 50 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.00494089 |
| 51 | positive regulation of B cell mediated immunity (GO:0002714) | 3.00494089 |
| 52 | regulation of vitamin metabolic process (GO:0030656) | 2.97560524 |
| 53 | regulation of tolerance induction (GO:0002643) | 2.96682059 |
| 54 | response to type I interferon (GO:0034340) | 2.96564834 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 2.94962958 |
| 56 | response to muramyl dipeptide (GO:0032495) | 2.94725500 |
| 57 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.92745787 |
| 58 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.92387608 |
| 59 | cellular response to interferon-gamma (GO:0071346) | 2.92289471 |
| 60 | regulation of chemokine biosynthetic process (GO:0045073) | 2.92263524 |
| 61 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.91340767 |
| 62 | regulation of mast cell activation (GO:0033003) | 2.91280258 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90979888 |
| 64 | neuron remodeling (GO:0016322) | 2.90224473 |
| 65 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.90044849 |
| 66 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.89482514 |
| 67 | tolerance induction (GO:0002507) | 2.88904437 |
| 68 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.88884591 |
| 69 | ceramide catabolic process (GO:0046514) | 2.87195078 |
| 70 | B cell mediated immunity (GO:0019724) | 2.87070129 |
| 71 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.86302213 |
| 72 | regulation of heat generation (GO:0031650) | 2.85146757 |
| 73 | negative regulation of innate immune response (GO:0045824) | 2.82809480 |
| 74 | positive regulation by symbiont of host defense response (GO:0052509) | 2.82705798 |
| 75 | modulation by symbiont of host defense response (GO:0052031) | 2.82705798 |
| 76 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.82705798 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.82705798 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.82705798 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 2.82705798 |
| 80 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.81607153 |
| 81 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.81607153 |
| 82 | response to interferon-gamma (GO:0034341) | 2.81534381 |
| 83 | detection of other organism (GO:0098543) | 2.80573883 |
| 84 | microglial cell activation (GO:0001774) | 2.80328126 |
| 85 | positive regulation of leukocyte degranulation (GO:0043302) | 2.79545164 |
| 86 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.79167295 |
| 87 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.78518767 |
| 88 | T-helper cell differentiation (GO:0042093) | 2.78518767 |
| 89 | cellular response to lipopolysaccharide (GO:0071222) | 2.78196826 |
| 90 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.77440139 |
| 91 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.77140959 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74871595 |
| 93 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.73001310 |
| 94 | cellular response to molecule of bacterial origin (GO:0071219) | 2.72702798 |
| 95 | positive regulation of protein kinase C signaling (GO:0090037) | 2.72182895 |
| 96 | * T-helper 1 type immune response (GO:0042088) | 2.71766918 |
| 97 | intracellular pH reduction (GO:0051452) | 2.70822940 |
| 98 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.67973276 |
| 99 | cellular response to interferon-beta (GO:0035458) | 2.67611825 |
| 100 | response to lipoprotein particle (GO:0055094) | 2.66944549 |
| 101 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.63755778 |
| 102 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.63617500 |
| 103 | response to interferon-beta (GO:0035456) | 2.63139407 |
| 104 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.60667354 |
| 105 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60436986 |
| 106 | L-phenylalanine catabolic process (GO:0006559) | 2.60436986 |
| 107 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.56754433 |
| 108 | amyloid precursor protein catabolic process (GO:0042987) | 2.56195055 |
| 109 | myelination (GO:0042552) | 2.56159671 |
| 110 | ensheathment of neurons (GO:0007272) | 2.54648398 |
| 111 | axon ensheathment (GO:0008366) | 2.54648398 |
| 112 | eosinophil chemotaxis (GO:0048245) | 2.54434571 |
| 113 | amyloid precursor protein metabolic process (GO:0042982) | 2.51937701 |
| 114 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.49855332 |
| 115 | granulocyte activation (GO:0036230) | 2.47700936 |
| 116 | positive regulation of type 2 immune response (GO:0002830) | 2.47653399 |
| 117 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.45903006 |
| 118 | presynaptic membrane assembly (GO:0097105) | 2.45308522 |
| 119 | response to peptidoglycan (GO:0032494) | 2.42823663 |
| 120 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.42550217 |
| 121 | regulation of interleukin-17 production (GO:0032660) | 2.42378390 |
| 122 | photoreceptor cell differentiation (GO:0046530) | 2.41686279 |
| 123 | eye photoreceptor cell differentiation (GO:0001754) | 2.41686279 |
| 124 | L-amino acid import (GO:0043092) | 2.41280349 |
| 125 | neutrophil activation (GO:0042119) | 2.39390272 |
| 126 | aldehyde catabolic process (GO:0046185) | 2.38201300 |
| 127 | respiratory burst (GO:0045730) | 2.37924061 |
| 128 | response to methylmercury (GO:0051597) | 2.33954214 |
| 129 | monocyte chemotaxis (GO:0002548) | 2.33442741 |
| 130 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.33009776 |
| 131 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.32268492 |
| 132 | oligodendrocyte differentiation (GO:0048709) | 2.31333829 |
| 133 | response to interferon-alpha (GO:0035455) | 2.31254368 |
| 134 | regulation of immunoglobulin secretion (GO:0051023) | 2.30452250 |
| 135 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.30373529 |
| 136 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.29900779 |
| 137 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.29549957 |
| 138 | virion attachment to host cell (GO:0019062) | 2.27419703 |
| 139 | adhesion of symbiont to host cell (GO:0044650) | 2.27419703 |
| 140 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.27182411 |
| 141 | positive regulation of T cell cytokine production (GO:0002726) | 2.26370531 |
| 142 | eosinophil migration (GO:0072677) | 2.25507738 |
| 143 | presynaptic membrane organization (GO:0097090) | 2.24753837 |
| 144 | positive regulation of interleukin-12 production (GO:0032735) | 2.23654279 |
| 145 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.23279653 |
| 146 | regulation of pigment cell differentiation (GO:0050932) | 2.22741098 |
| 147 | positive regulation of interferon-alpha production (GO:0032727) | 2.21552369 |
| 148 | cellular response to interferon-alpha (GO:0035457) | 2.20662006 |
| 149 | pH reduction (GO:0045851) | 2.20550411 |
| 150 | superoxide anion generation (GO:0042554) | 2.20533931 |
| 151 | import into cell (GO:0098657) | 2.19257848 |
| 152 | positive regulation of antigen processing and presentation (GO:0002579) | 2.15985443 |
| 153 | positive regulation of T cell migration (GO:2000406) | 2.15123900 |
| 154 | regulation of T-helper cell differentiation (GO:0045622) | 2.13902652 |
| 155 | amino acid import (GO:0043090) | 2.13503667 |
| 156 | lymphocyte chemotaxis (GO:0048247) | 2.13205231 |
| 157 | regulation of interferon-alpha production (GO:0032647) | 2.12721474 |
| 158 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.12518803 |
| 159 | positive regulation of lymphocyte migration (GO:2000403) | 2.11349262 |
| 160 | glycerophospholipid catabolic process (GO:0046475) | 2.11332079 |
| 161 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.11290826 |
| 162 | regulation of T cell migration (GO:2000404) | 2.09866063 |
| 163 | positive regulation of acute inflammatory response (GO:0002675) | 2.09674133 |
| 164 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.08861548 |
| 165 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.08316313 |
| 166 | L-phenylalanine metabolic process (GO:0006558) | 2.08316313 |
| 167 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.08041683 |
| 168 | opsonization (GO:0008228) | 2.06985607 |
| 169 | defense response to protozoan (GO:0042832) | 2.06788185 |
| 170 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.06586943 |
| 171 | cellular response to exogenous dsRNA (GO:0071360) | 2.06126866 |
| 172 | regulation of hypersensitivity (GO:0002883) | 2.05971525 |
| 173 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.05925278 |
| 174 | limb bud formation (GO:0060174) | 2.05395897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.70046290 |
| 2 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.98810180 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.92589044 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.78877611 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.66309328 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60777904 |
| 7 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.55022881 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50199936 |
| 9 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.41789694 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32963545 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.28657285 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.28251151 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.26462458 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24707558 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24336581 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16847848 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.14475136 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.09839789 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06221923 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05134584 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.04716081 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97095060 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.95844141 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93510418 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88805610 |
| 26 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.81407847 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.81228256 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81191729 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.79963760 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.79170431 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.78409270 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.74332002 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.73921210 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70495979 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70317307 |
| 36 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70108852 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.68346179 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67816352 |
| 39 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.66530083 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66259647 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.64234856 |
| 42 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60390789 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59752061 |
| 44 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.56705794 |
| 45 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55816731 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55076557 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54839333 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.52443354 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52086871 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51843535 |
| 51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50051857 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49362401 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48028135 |
| 54 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.47593239 |
| 55 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46341638 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45057146 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43824669 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43645131 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.43575812 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41440067 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40539098 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40157359 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39488101 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38165157 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38040557 |
| 66 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37642069 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37271356 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37242915 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36092631 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36048713 |
| 71 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36043488 |
| 72 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35972615 |
| 73 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35335333 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.35075359 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34163916 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33962140 |
| 77 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.33807850 |
| 78 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.32512559 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31980671 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31655527 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30837117 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30096462 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30096462 |
| 84 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.29998490 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27346603 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26931199 |
| 87 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.26582206 |
| 88 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.26582206 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26373494 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26069954 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25448166 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 1.25181609 |
| 93 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22475072 |
| 94 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22347529 |
| 95 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.22178988 |
| 96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21448059 |
| 97 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21310662 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20849105 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20666724 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19035486 |
| 101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18373253 |
| 102 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17980337 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17186269 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17135592 |
| 105 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15905623 |
| 106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15454664 |
| 107 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14612412 |
| 108 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14391564 |
| 109 | MYB_26560356_Chip-Seq_TH1_Human | 1.14292502 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14060819 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13946760 |
| 112 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.13712588 |
| 113 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.12830306 |
| 114 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12798453 |
| 115 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12050183 |
| 116 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11861486 |
| 117 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11455228 |
| 118 | MYC_22102868_ChIP-Seq_BL_Human | 1.10896801 |
| 119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09697259 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09073409 |
| 121 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08576216 |
| 122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08024272 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07845152 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07822815 |
| 125 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07630085 |
| 126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06900848 |
| 127 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05905309 |
| 128 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05372383 |
| 129 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05214116 |
| 130 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.04802894 |
| 131 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04478725 |
| 132 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04301861 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04267982 |
| 134 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04163972 |
| 135 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02938615 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01916833 |
| 137 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00562603 |
| 138 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00464564 |
| 139 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00452355 |
| 140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00224876 |
| 141 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00050114 |
| 142 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00045337 |
| 143 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00037500 |
| 144 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99818707 |
| 145 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99384540 |
| 146 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98966300 |
| 147 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98154186 |
| 148 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97782897 |
| 149 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97745849 |
| 150 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96060248 |
| 151 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.95922123 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95351205 |
| 153 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95158435 |
| 154 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.94921089 |
| 155 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94811370 |
| 156 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94710565 |
| 157 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93289299 |
| 158 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92932844 |
| 159 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91676176 |
| 160 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91439817 |
| 161 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88822216 |
| 162 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88572562 |
| 163 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87608660 |
| 164 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85798946 |
| 165 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82573240 |
| 166 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82086381 |
| 167 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.80108360 |
| 168 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80023750 |
| 169 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79363472 |
| 170 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.78126851 |
| 171 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77584075 |
| 172 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.77532892 |
| 173 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.77532892 |
| 174 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.77532892 |
| 175 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.76847350 |
| 176 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75467994 |
| 177 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.75322730 |
| 178 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74375640 |
| 179 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.69074594 |
| 180 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.68733397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.34329240 |
| 2 | MP0003136_yellow_coat_color | 3.25666643 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.19650580 |
| 4 | MP0009785_altered_susceptibility_to | 2.83758325 |
| 5 | MP0000920_abnormal_myelination | 2.72123510 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.57861841 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.52430257 |
| 8 | MP0004381_abnormal_hair_follicle | 2.48128990 |
| 9 | MP0005409_darkened_coat_color | 2.45157929 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.27434144 |
| 11 | MP0003880_abnormal_central_pattern | 2.25664287 |
| 12 | MP0006082_CNS_inflammation | 2.21985647 |
| 13 | MP0003690_abnormal_glial_cell | 2.20486035 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.19658203 |
| 15 | MP0003436_decreased_susceptibility_to | 2.17049993 |
| 16 | MP0005387_immune_system_phenotype | 2.10151580 |
| 17 | MP0001790_abnormal_immune_system | 2.10151580 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.07740772 |
| 19 | MP0005025_abnormal_response_to | 2.06767801 |
| 20 | MP0002419_abnormal_innate_immunity | 1.93055081 |
| 21 | MP0001873_stomach_inflammation | 1.80160066 |
| 22 | MP0004510_myositis | 1.76528682 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.70770208 |
| 24 | MP0004742_abnormal_vestibular_system | 1.69462630 |
| 25 | MP0001851_eye_inflammation | 1.67142783 |
| 26 | MP0002254_reproductive_system_inflammat | 1.64907237 |
| 27 | MP0003303_peritoneal_inflammation | 1.60631843 |
| 28 | MP0005671_abnormal_response_to | 1.60477039 |
| 29 | MP0000685_abnormal_immune_system | 1.59125765 |
| 30 | MP0005360_urolithiasis | 1.59115146 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.57390246 |
| 32 | MP0002723_abnormal_immune_serum | 1.48287228 |
| 33 | MP0009278_abnormal_bone_marrow | 1.47962895 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.46741487 |
| 35 | MP0005083_abnormal_biliary_tract | 1.45149971 |
| 36 | MP0000716_abnormal_immune_system | 1.42077438 |
| 37 | MP0005451_abnormal_body_composition | 1.41933336 |
| 38 | MP0009764_decreased_sensitivity_to | 1.38843543 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.38462439 |
| 40 | MP0001800_abnormal_humoral_immune | 1.36357653 |
| 41 | MP0005423_abnormal_somatic_nervous | 1.35241308 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.33846322 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.33055631 |
| 44 | MP0003195_calcinosis | 1.32843496 |
| 45 | MP0005379_endocrine/exocrine_gland_phen | 1.30432235 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.30252446 |
| 47 | MP0008004_abnormal_stomach_pH | 1.29323571 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.29194492 |
| 49 | MP0005164_abnormal_response_to | 1.28631763 |
| 50 | MP0003950_abnormal_plasma_membrane | 1.27329670 |
| 51 | MP0000604_amyloidosis | 1.27289224 |
| 52 | MP0005171_absent_coat_pigmentation | 1.26706849 |
| 53 | MP0001346_abnormal_lacrimal_gland | 1.23606709 |
| 54 | MP0001663_abnormal_digestive_system | 1.23304898 |
| 55 | MP0003011_delayed_dark_adaptation | 1.23041106 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21912004 |
| 57 | MP0005166_decreased_susceptibility_to | 1.21844332 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.21604522 |
| 59 | MP0001905_abnormal_dopamine_level | 1.20966284 |
| 60 | MP0008469_abnormal_protein_level | 1.20669815 |
| 61 | MP0004142_abnormal_muscle_tone | 1.19272453 |
| 62 | MP0000858_altered_metastatic_potential | 1.15352937 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.15309916 |
| 64 | MP0002398_abnormal_bone_marrow | 1.12506813 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.10625570 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.10625570 |
| 67 | MP0003634_abnormal_glial_cell | 1.08963990 |
| 68 | MP0000383_abnormal_hair_follicle | 1.08206386 |
| 69 | MP0005174_abnormal_tail_pigmentation | 1.05231009 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.03026833 |
| 71 | MP0004885_abnormal_endolymph | 1.02969319 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.02942558 |
| 73 | MP0002429_abnormal_blood_cell | 1.02128651 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.01249075 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 1.00611470 |
| 76 | MP0001819_abnormal_immune_cell | 1.00124175 |
| 77 | MP0001486_abnormal_startle_reflex | 0.98748780 |
| 78 | MP0003075_altered_response_to | 0.97354081 |
| 79 | MP0002420_abnormal_adaptive_immunity | 0.96020837 |
| 80 | MP0001853_heart_inflammation | 0.94313990 |
| 81 | MP0009763_increased_sensitivity_to | 0.93600713 |
| 82 | MP0001879_abnormal_lymphatic_vessel | 0.91801713 |
| 83 | MP0001845_abnormal_inflammatory_respons | 0.91753270 |
| 84 | MP0002064_seizures | 0.91231906 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.88315206 |
| 86 | MP0005464_abnormal_platelet_physiology | 0.88231218 |
| 87 | MP0010678_abnormal_skin_adnexa | 0.87843057 |
| 88 | MP0000778_abnormal_nervous_system | 0.87571244 |
| 89 | MP0002722_abnormal_immune_system | 0.86581069 |
| 90 | MP0001188_hyperpigmentation | 0.85509566 |
| 91 | MP0005390_skeleton_phenotype | 0.85460541 |
| 92 | MP0004947_skin_inflammation | 0.85077058 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.84545701 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 0.84381003 |
| 95 | MP0005381_digestive/alimentary_phenotyp | 0.84314693 |
| 96 | MP0009840_abnormal_foam_cell | 0.84211400 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.83858442 |
| 98 | MP0003448_altered_tumor_morphology | 0.82888250 |
| 99 | MP0003329_amyloid_beta_deposits | 0.80508210 |
| 100 | MP0005310_abnormal_salivary_gland | 0.80403273 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.80146658 |
| 102 | MP0005647_abnormal_sex_gland | 0.78559497 |
| 103 | MP0006276_abnormal_autonomic_nervous | 0.78277008 |
| 104 | MP0002272_abnormal_nervous_system | 0.77547683 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.76376223 |
| 106 | MP0002933_joint_inflammation | 0.76335066 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.76230249 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.75908127 |
| 109 | MP0000343_altered_response_to | 0.75525773 |
| 110 | MP0002229_neurodegeneration | 0.75300499 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.75123832 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.73429811 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.73033782 |
| 114 | MP0002405_respiratory_system_inflammati | 0.72994889 |
| 115 | MP0009745_abnormal_behavioral_response | 0.70711955 |
| 116 | MP0002166_altered_tumor_susceptibility | 0.68513126 |
| 117 | MP0002090_abnormal_vision | 0.67534804 |
| 118 | MP0003183_abnormal_peptide_metabolism | 0.67220306 |
| 119 | MP0004883_abnormal_blood_vessel | 0.66919577 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.66769257 |
| 121 | MP0003938_abnormal_ear_development | 0.66676726 |
| 122 | MP0000249_abnormal_blood_vessel | 0.66367518 |
| 123 | MP0001502_abnormal_circadian_rhythm | 0.65900048 |
| 124 | MP0010155_abnormal_intestine_physiology | 0.64755254 |
| 125 | MP0003866_abnormal_defecation | 0.64705164 |
| 126 | MP0005448_abnormal_energy_balance | 0.64540531 |
| 127 | MP0000026_abnormal_inner_ear | 0.64532712 |
| 128 | MP0005365_abnormal_bile_salt | 0.63946401 |
| 129 | MP0002132_abnormal_respiratory_system | 0.61896515 |
| 130 | MP0003806_abnormal_nucleotide_metabolis | 0.59403670 |
| 131 | MP0010307_abnormal_tumor_latency | 0.57002613 |
| 132 | MP0003091_abnormal_cell_migration | 0.55938094 |
| 133 | MP0000490_abnormal_crypts_of | 0.55849241 |
| 134 | MP0004019_abnormal_vitamin_homeostasis | 0.55414473 |
| 135 | MP0003656_abnormal_erythrocyte_physiolo | 0.53951143 |
| 136 | MP0003795_abnormal_bone_structure | 0.53671896 |
| 137 | MP0000703_abnormal_thymus_morphology | 0.53529409 |
| 138 | MP0003828_pulmonary_edema | 0.48619491 |
| 139 | MP0003879_abnormal_hair_cell | 0.45805495 |
| 140 | MP0008874_decreased_physiological_sensi | 0.45632277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.04083697 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.04083697 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.04083697 |
| 4 | Parakeratosis (HP:0001036) | 4.78080338 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.66761593 |
| 6 | Dysostosis multiplex (HP:0000943) | 4.20955018 |
| 7 | Disinhibition (HP:0000734) | 4.17961406 |
| 8 | Loss of speech (HP:0002371) | 4.10037437 |
| 9 | Neurofibrillary tangles (HP:0002185) | 3.91072046 |
| 10 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.62834236 |
| 11 | Abnormality of the axillary hair (HP:0100134) | 3.57124863 |
| 12 | Abnormality of secondary sexual hair (HP:0009888) | 3.57124863 |
| 13 | Mutism (HP:0002300) | 3.56912384 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.55005032 |
| 15 | Orchitis (HP:0100796) | 3.54156062 |
| 16 | Myositis (HP:0100614) | 3.53022268 |
| 17 | Stomatitis (HP:0010280) | 3.42977576 |
| 18 | Prolonged partial thromboplastin time (HP:0003645) | 3.36470581 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.31705793 |
| 20 | Flat occiput (HP:0005469) | 3.31494850 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.30246422 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.17054255 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01761217 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01761217 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01761217 |
| 26 | Joint hemorrhage (HP:0005261) | 3.01227249 |
| 27 | Eczematoid dermatitis (HP:0000976) | 2.98605940 |
| 28 | Thick nail (HP:0001805) | 2.97692991 |
| 29 | Keratoconjunctivitis (HP:0001096) | 2.96421349 |
| 30 | Abnormal ciliary motility (HP:0012262) | 2.93888071 |
| 31 | Abnormality of macrophages (HP:0004311) | 2.93791260 |
| 32 | Axonal loss (HP:0003447) | 2.87304686 |
| 33 | Absent/shortened dynein arms (HP:0200106) | 2.85752564 |
| 34 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.85752564 |
| 35 | Mucopolysacchariduria (HP:0008155) | 2.83138055 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.83138055 |
| 37 | Increased IgM level (HP:0003496) | 2.75171560 |
| 38 | Amyloidosis (HP:0011034) | 2.73299684 |
| 39 | Pustule (HP:0200039) | 2.71664906 |
| 40 | Recurrent skin infections (HP:0001581) | 2.71567649 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.68083729 |
| 42 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.65010347 |
| 43 | Increased serum ferritin (HP:0003281) | 2.63918177 |
| 44 | Hematochezia (HP:0002573) | 2.61670891 |
| 45 | Glomerulonephritis (HP:0000099) | 2.59654056 |
| 46 | Renal Fanconi syndrome (HP:0001994) | 2.58627020 |
| 47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57889670 |
| 48 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.54036775 |
| 49 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.52626353 |
| 50 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.50501609 |
| 51 | Nuclear cataract (HP:0100018) | 2.49613285 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.48772503 |
| 53 | T lymphocytopenia (HP:0005403) | 2.42309411 |
| 54 | Recurrent viral infections (HP:0004429) | 2.41267800 |
| 55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.41043031 |
| 56 | Chronic otitis media (HP:0000389) | 2.40198376 |
| 57 | Meningitis (HP:0001287) | 2.38968533 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.38538513 |
| 59 | Inappropriate behavior (HP:0000719) | 2.37697611 |
| 60 | Cerebral inclusion bodies (HP:0100314) | 2.37429232 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.33458218 |
| 62 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.32812174 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.32743676 |
| 64 | Encephalitis (HP:0002383) | 2.31500099 |
| 65 | Cerebral hemorrhage (HP:0001342) | 2.30786659 |
| 66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.28754667 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.27535077 |
| 68 | Obstructive lung disease (HP:0006536) | 2.25474791 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.25474791 |
| 70 | Agnosia (HP:0010524) | 2.25269982 |
| 71 | Erythroderma (HP:0001019) | 2.21901338 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 2.19245339 |
| 73 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.18873024 |
| 74 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.18873024 |
| 75 | Congenital sensorineural hearing impairment (HP:0008527) | 2.17614210 |
| 76 | Polyneuropathy (HP:0001271) | 2.16667174 |
| 77 | Purpura (HP:0000979) | 2.12809171 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.12502677 |
| 79 | Anorexia (HP:0002039) | 2.09841748 |
| 80 | Metaphyseal irregularity (HP:0003025) | 2.08032222 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.07818681 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06578579 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06578579 |
| 84 | Hyperlipoproteinemia (HP:0010980) | 2.06137553 |
| 85 | Apathy (HP:0000741) | 2.06101632 |
| 86 | Hypophosphatemic rickets (HP:0004912) | 2.04363480 |
| 87 | Chronic sinusitis (HP:0011109) | 2.04230589 |
| 88 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.03907382 |
| 89 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.03907382 |
| 90 | Congenital, generalized hypertrichosis (HP:0004540) | 2.03686285 |
| 91 | Neuronal loss in central nervous system (HP:0002529) | 2.03256740 |
| 92 | Poor head control (HP:0002421) | 2.02370040 |
| 93 | Abnormality of renal resorption (HP:0011038) | 2.00467198 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 2.00231587 |
| 95 | Gingival bleeding (HP:0000225) | 1.99659175 |
| 96 | Diminished motivation (HP:0000745) | 1.98774710 |
| 97 | 3-Methylglutaconic aciduria (HP:0003535) | 1.97861787 |
| 98 | Gingivitis (HP:0000230) | 1.97263094 |
| 99 | Restrictive lung disease (HP:0002091) | 1.96901251 |
| 100 | Patchy hypopigmentation of hair (HP:0011365) | 1.96858358 |
| 101 | White forelock (HP:0002211) | 1.96366480 |
| 102 | Gangrene (HP:0100758) | 1.96327091 |
| 103 | Increased IgE level (HP:0003212) | 1.96008469 |
| 104 | Stomach cancer (HP:0012126) | 1.95377196 |
| 105 | Peripheral hypomyelination (HP:0007182) | 1.95017562 |
| 106 | Autoimmune thrombocytopenia (HP:0001973) | 1.94768651 |
| 107 | Vasculitis (HP:0002633) | 1.94763635 |
| 108 | Basal ganglia calcification (HP:0002135) | 1.94395633 |
| 109 | Prolonged neonatal jaundice (HP:0006579) | 1.93010249 |
| 110 | Decreased central vision (HP:0007663) | 1.92416480 |
| 111 | Humeroradial synostosis (HP:0003041) | 1.92361680 |
| 112 | Synostosis involving the elbow (HP:0003938) | 1.92361680 |
| 113 | Hypergammaglobulinemia (HP:0010702) | 1.90765798 |
| 114 | Onion bulb formation (HP:0003383) | 1.90653251 |
| 115 | Colitis (HP:0002583) | 1.90018569 |
| 116 | Menorrhagia (HP:0000132) | 1.89833058 |
| 117 | Metabolic alkalosis (HP:0200114) | 1.88589553 |
| 118 | Abnormality of T cells (HP:0002843) | 1.88067243 |
| 119 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.87934035 |
| 120 | Abnormality of the pleura (HP:0002103) | 1.86885700 |
| 121 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86362594 |
| 122 | Abnormality of B cell number (HP:0010975) | 1.84888340 |
| 123 | Bone cyst (HP:0012062) | 1.84633119 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84308724 |
| 125 | Global brain atrophy (HP:0002283) | 1.84280050 |
| 126 | Complement deficiency (HP:0004431) | 1.83995442 |
| 127 | Petechiae (HP:0000967) | 1.83917212 |
| 128 | Abnormality of eosinophils (HP:0001879) | 1.83164631 |
| 129 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83133113 |
| 130 | Xanthomatosis (HP:0000991) | 1.83129743 |
| 131 | Intrahepatic cholestasis (HP:0001406) | 1.81123307 |
| 132 | Abnormality of the nasal mucosa (HP:0000433) | 1.80950991 |
| 133 | Memory impairment (HP:0002354) | 1.80470297 |
| 134 | Sensory axonal neuropathy (HP:0003390) | 1.79689000 |
| 135 | Hypothermia (HP:0002045) | 1.78929334 |
| 136 | Dementia (HP:0000726) | 1.78476115 |
| 137 | Increased hepatocellular lipid droplets (HP:0006565) | 1.77757885 |
| 138 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77085918 |
| 139 | Progressive inability to walk (HP:0002505) | 1.76025808 |
| 140 | Nasal polyposis (HP:0100582) | 1.74830053 |
| 141 | Eosinophilia (HP:0001880) | 1.72065800 |
| 142 | Myocardial infarction (HP:0001658) | 1.70858343 |
| 143 | Urticaria (HP:0001025) | 1.70635217 |
| 144 | Leukocytosis (HP:0001974) | 1.69475741 |
| 145 | Peripheral demyelination (HP:0011096) | 1.68427933 |
| 146 | Hemiparesis (HP:0001269) | 1.67731228 |
| 147 | Retrobulbar optic neuritis (HP:0100654) | 1.67560289 |
| 148 | Optic neuritis (HP:0100653) | 1.67560289 |
| 149 | Gastrointestinal infarctions (HP:0005244) | 1.67547453 |
| 150 | Conjunctival telangiectasia (HP:0000524) | 1.65921082 |
| 151 | Spontaneous hematomas (HP:0007420) | 1.65066098 |
| 152 | Supranuclear gaze palsy (HP:0000605) | 1.64908231 |
| 153 | Recurrent fungal infections (HP:0002841) | 1.63066750 |
| 154 | Hypoplasia of the iris (HP:0007676) | 1.60446996 |
| 155 | Pruritus (HP:0000989) | 1.60304104 |
| 156 | Hemoptysis (HP:0002105) | 1.60205622 |
| 157 | Abnormal pupillary function (HP:0007686) | 1.60058741 |
| 158 | Submucous cleft hard palate (HP:0000176) | 1.59779716 |
| 159 | Cupped ear (HP:0000378) | 1.59604155 |
| 160 | Nephritis (HP:0000123) | 1.59472345 |
| 161 | Deep venous thrombosis (HP:0002625) | 1.59001229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 3.41717970 |
| 2 | STK39 | 2.96349892 |
| 3 | MAP4K1 | 2.84010587 |
| 4 | EPHB1 | 2.72869624 |
| 5 | CASK | 2.65257142 |
| 6 | BLK | 2.63246786 |
| 7 | MAP3K14 | 2.36667884 |
| 8 | MATK | 2.35002887 |
| 9 | PKN1 | 2.27965844 |
| 10 | IRAK3 | 2.22258375 |
| 11 | DDR2 | 2.17873450 |
| 12 | PASK | 2.06238571 |
| 13 | TAOK1 | 2.06037370 |
| 14 | BMPR1B | 2.03535320 |
| 15 | FGR | 1.98999836 |
| 16 | MST4 | 1.95021368 |
| 17 | TNIK | 1.89744300 |
| 18 | IKBKE | 1.85177746 |
| 19 | BCR | 1.81282359 |
| 20 | MAPK15 | 1.79243604 |
| 21 | PNCK | 1.76883862 |
| 22 | MUSK | 1.75319815 |
| 23 | OXSR1 | 1.74186941 |
| 24 | MAP3K11 | 1.71509160 |
| 25 | ACVR1B | 1.71191492 |
| 26 | RIPK4 | 1.67081964 |
| 27 | GRK7 | 1.66025561 |
| 28 | FES | 1.65742976 |
| 29 | TYK2 | 1.59214398 |
| 30 | TAOK2 | 1.56614569 |
| 31 | IRAK4 | 1.55165638 |
| 32 | CHUK | 1.53582072 |
| 33 | CDC42BPA | 1.52447647 |
| 34 | INSRR | 1.50916525 |
| 35 | TBK1 | 1.48694500 |
| 36 | TAOK3 | 1.48425865 |
| 37 | ZAP70 | 1.45844322 |
| 38 | MAPKAPK5 | 1.39078075 |
| 39 | IRAK1 | 1.38325583 |
| 40 | ITK | 1.32444444 |
| 41 | ERN1 | 1.30647703 |
| 42 | PRPF4B | 1.25020675 |
| 43 | CSF1R | 1.21130091 |
| 44 | CSK | 1.20647876 |
| 45 | IKBKB | 1.19517993 |
| 46 | TYRO3 | 1.18384948 |
| 47 | KIT | 1.16223285 |
| 48 | MAP2K3 | 1.13179237 |
| 49 | GRK1 | 1.12512236 |
| 50 | MAP3K3 | 1.11010065 |
| 51 | FGFR4 | 1.09751935 |
| 52 | TLK1 | 1.07770766 |
| 53 | WNK4 | 1.07351881 |
| 54 | IRAK2 | 1.06199748 |
| 55 | CAMKK1 | 0.99138125 |
| 56 | JAK1 | 0.96656639 |
| 57 | BTK | 0.95510103 |
| 58 | MST1R | 0.93911941 |
| 59 | WNK1 | 0.91657492 |
| 60 | MARK3 | 0.91323317 |
| 61 | TGFBR1 | 0.89885015 |
| 62 | DYRK3 | 0.89274849 |
| 63 | EPHA3 | 0.88532483 |
| 64 | PRKCQ | 0.87786334 |
| 65 | BMPR2 | 0.87623347 |
| 66 | ADRBK2 | 0.87574758 |
| 67 | YES1 | 0.86948666 |
| 68 | MAP2K2 | 0.86858762 |
| 69 | TGFBR2 | 0.86850336 |
| 70 | MAPK7 | 0.85362330 |
| 71 | CAMK2B | 0.84775659 |
| 72 | NLK | 0.84683194 |
| 73 | RPS6KA5 | 0.84043576 |
| 74 | CSNK1A1L | 0.82355075 |
| 75 | TESK2 | 0.81898419 |
| 76 | TXK | 0.81446307 |
| 77 | LCK | 0.81432648 |
| 78 | MOS | 0.80716254 |
| 79 | SIK1 | 0.80338998 |
| 80 | PIM2 | 0.79772031 |
| 81 | PRKCE | 0.79526082 |
| 82 | CSNK1G3 | 0.77686492 |
| 83 | JAK2 | 0.77217792 |
| 84 | MAP3K1 | 0.75705063 |
| 85 | CAMKK2 | 0.74180945 |
| 86 | CAMK2D | 0.73782145 |
| 87 | LYN | 0.73082395 |
| 88 | MAP2K6 | 0.73074162 |
| 89 | DAPK2 | 0.72973068 |
| 90 | CLK1 | 0.72502913 |
| 91 | RIPK1 | 0.71985728 |
| 92 | DYRK2 | 0.71671353 |
| 93 | EPHB2 | 0.70198496 |
| 94 | NME1 | 0.68351284 |
| 95 | CAMK1D | 0.67893331 |
| 96 | MET | 0.67494545 |
| 97 | CAMK1G | 0.66930756 |
| 98 | NEK6 | 0.66714103 |
| 99 | EIF2AK2 | 0.66404281 |
| 100 | JAK3 | 0.66235319 |
| 101 | PIM1 | 0.63786811 |
| 102 | CSNK1G1 | 0.63644037 |
| 103 | HCK | 0.62781593 |
| 104 | HIPK2 | 0.61995003 |
| 105 | CAMK2G | 0.60419748 |
| 106 | NUAK1 | 0.59932715 |
| 107 | CAMK2A | 0.58920734 |
| 108 | PRKG1 | 0.58739477 |
| 109 | SYK | 0.57960024 |
| 110 | MAP3K13 | 0.57664394 |
| 111 | TIE1 | 0.56997155 |
| 112 | STK16 | 0.56826859 |
| 113 | NME2 | 0.55837935 |
| 114 | PIK3CG | 0.55092261 |
| 115 | UHMK1 | 0.51723231 |
| 116 | PRKD2 | 0.51496295 |
| 117 | GSK3A | 0.51403359 |
| 118 | CSNK1G2 | 0.50609884 |
| 119 | STK10 | 0.50271817 |
| 120 | ABL1 | 0.50086158 |
| 121 | ABL2 | 0.49235072 |
| 122 | DYRK1B | 0.48188891 |
| 123 | PRKAA2 | 0.47611462 |
| 124 | CDK3 | 0.47288459 |
| 125 | MAP3K10 | 0.46587423 |
| 126 | TNK2 | 0.46563752 |
| 127 | NEK9 | 0.46026653 |
| 128 | TEC | 0.45914202 |
| 129 | FYN | 0.45795348 |
| 130 | MAPK4 | 0.44988551 |
| 131 | ADRBK1 | 0.43642970 |
| 132 | CDK9 | 0.43509842 |
| 133 | ROCK2 | 0.42646043 |
| 134 | STK11 | 0.42257756 |
| 135 | SIK2 | 0.42164421 |
| 136 | EPHA4 | 0.41472608 |
| 137 | MAPK13 | 0.41091781 |
| 138 | GRK6 | 0.41029728 |
| 139 | PRKCD | 0.40598086 |
| 140 | MARK2 | 0.40586805 |
| 141 | MAPK12 | 0.40191943 |
| 142 | PRKD1 | 0.39210045 |
| 143 | RPS6KA6 | 0.38399897 |
| 144 | RPS6KL1 | 0.35980010 |
| 145 | RPS6KC1 | 0.35980010 |
| 146 | MAP3K5 | 0.34522314 |
| 147 | CDK4 | 0.33513765 |
| 148 | INSR | 0.26003546 |
| 149 | PDK1 | 0.24442389 |
| 150 | STK24 | 0.20734620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.88039386 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.24096651 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.16299014 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.13943457 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.13594356 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.06263476 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.01645330 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88667258 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.87956592 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.83632438 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83387972 |
| 12 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.80632900 |
| 13 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.73565792 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.73187102 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69312852 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65734055 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.58050900 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.58008472 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50931106 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.50747603 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50338370 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.47692192 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.46364981 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45509273 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.44178429 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.43699729 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38313110 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37851384 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37162713 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35413251 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34623751 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32985691 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.32419216 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.30462931 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28333367 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27730564 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.23685505 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.21694838 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19056055 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17841857 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17544069 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16401281 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13524061 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13495422 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12547873 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09393527 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09065984 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08819397 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.98944254 |
| 50 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96172287 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95155187 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94182274 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93392107 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93041606 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92753416 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90427474 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89516710 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89155499 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87921558 |
| 60 | Measles_Homo sapiens_hsa05162 | 0.87404807 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86225130 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.85140225 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84102364 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83654269 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.82146099 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81081504 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81003043 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.80698460 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.79610732 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.78602096 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78073519 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77984440 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.77651712 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.77228613 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76739840 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75457290 |
| 77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73420680 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72824857 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.72254720 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71657201 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.70747038 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69344198 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.68870154 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67618365 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66511304 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65301469 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65254569 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65218046 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64136039 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.63381230 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63143447 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61086123 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61005917 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60339663 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60061730 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.59999092 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59908116 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59651676 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58907628 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55927308 |
| 101 | Ribosome_Homo sapiens_hsa03010 | 0.53621599 |
| 102 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53587129 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.53199723 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53076791 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.51791365 |
| 106 | Axon guidance_Homo sapiens_hsa04360 | 0.51666432 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.49307341 |
| 108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48657228 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48182396 |
| 110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47801492 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46072752 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45738567 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45514704 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45136415 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44461926 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44099668 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43579719 |
| 118 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43546187 |
| 119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41596490 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.41219458 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39325307 |
| 122 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.38593134 |
| 123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38559555 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.36172281 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35999934 |
| 126 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35201603 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28068851 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.27832080 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25462430 |
| 130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24908625 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22067031 |
| 132 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22045229 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20675010 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20541227 |
| 135 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.19777397 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18813420 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17630462 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17327629 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16323970 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14824089 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.14188501 |
| 142 | Platelet activation_Homo sapiens_hsa04611 | 0.11935279 |

